Have an ongoing history of bradyarrhythmia and/or sinus bradycardia
Have an elevated resting pulse rate (greater than 100 bpm) or reduced resting pulse rate (less than 60 bpm)
Have a history of acute or chronic pancreatitis
All concomitant medications should be at a stable dose for at least 3 months prior to screening
Clareo Health | A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
